Global Pharma-Grade Hyaluronic Acid Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Pharma-Grade Hyaluronic Acid Market
Hyaluronic acid is a naturally occurring substance that helps retain moisture in the skin and eyes and lubricates the joints. Hyaluronic Acid is generally used in pharmaceutical formulations, such as auxiliary agents for eye surgery and therapeutic agents for osteoarthritis of the knee joint.

Due to the COVID-19 pandemic, the global Pharma-Grade Hyaluronic Acid market size is estimated to be worth US$ 150.3 million in 2022 and is forecast to a readjusted size of US$ 276.7 million by 2028 with a CAGR of 10.7% during the review period. Fully considering the economic change by this health crisis, Injection Grade Hyaluronic Acid accounting for % of the Pharma-Grade Hyaluronic Acid global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Auxiliary Agents for Eye Surgery segment is altered to an % CAGR throughout this forecast period.

Global pharma-grade hyaluronic acid includes Bloomage BioTechnology, AWA Biopharm, etc. Global top 3 companies hold a share about 70%.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Injection Grade Hyaluronic Acid

Eye Drops Grade Hyaluronic Acid

Segment by Application

Auxiliary Agents for Eye Surgery

Therapeutic Agents

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Pharma-Grade Hyaluronic Acid market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Bloomage BioTechnology

AWA Biopharm

Kewpie

Contipro

Seikagaku

HTL Biotechnology

Fidia Farmaceutici

TABLE OF CONTENT

1 Study Coverage
1.1 Pharma-Grade Hyaluronic Acid Product Introduction

1.2 Market by Type

1.2.1 Global Pharma-Grade Hyaluronic Acid Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Injection Grade Hyaluronic Acid

1.2.3 Eye Drops Grade Hyaluronic Acid

1.3 Market by Application

1.3.1 Global Pharma-Grade Hyaluronic Acid Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Auxiliary Agents for Eye Surgery

1.3.3 Therapeutic Agents

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Pharma-Grade Hyaluronic Acid Sales Estimates and Forecasts 2017-2028

2.2 Global Pharma-Grade Hyaluronic Acid Revenue Estimates and Forecasts 2017-2028

2.3 Global Pharma-Grade Hyaluronic Acid Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Pharma-Grade Hyaluronic Acid Sales by Region

2.4.1 Global Pharma-Grade Hyaluronic Acid Sales by Region (2017-2022)

2.4.2 Global Sales Pharma-Grade Hyaluronic Acid by Region (2023-2028)

2.5 Global Pharma-Grade Hyaluronic Acid Revenue by Region

2.5.1 Global Pharma-Grade Hyaluronic Acid Revenue by Region (2017-2022)

2.5.2 Global Pharma-Grade Hyaluronic Acid Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Pharma-Grade Hyaluronic Acid Sales by Manufacturers

3.1.1 Global Top Pharma-Grade Hyaluronic Acid Manufacturers by Sales (2017-2022)

3.1.2 Global Pharma-Grade Hyaluronic Acid Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pharma-Grade Hyaluronic Acid in 2021

3.2 Global Pharma-Grade Hyaluronic Acid Revenue by Manufacturers

3.2.1 Global Pharma-Grade Hyaluronic Acid Revenue by Manufacturers (2017-2022)

3.2.2 Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Pharma-Grade Hyaluronic Acid Revenue in 2021

3.3 Global Pharma-Grade Hyaluronic Acid Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Pharma-Grade Hyaluronic Acid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Pharma-Grade Hyaluronic Acid Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Pharma-Grade Hyaluronic Acid Sales by Type

4.1.1 Global Pharma-Grade Hyaluronic Acid Historical Sales by Type (2017-2022)

4.1.2 Global Pharma-Grade Hyaluronic Acid Forecasted Sales by Type (2023-2028)

4.1.3 Global Pharma-Grade Hyaluronic Acid Sales Market Share by Type (2017-2028)

4.2 Global Pharma-Grade Hyaluronic Acid Revenue by Type

4.2.1 Global Pharma-Grade Hyaluronic Acid Historical Revenue by Type (2017-2022)

4.2.2 Global Pharma-Grade Hyaluronic Acid Forecasted Revenue by Type (2023-2028)

4.2.3 Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Type (2017-2028)

4.3 Global Pharma-Grade Hyaluronic Acid Price by Type

4.3.1 Global Pharma-Grade Hyaluronic Acid Price by Type (2017-2022)

4.3.2 Global Pharma-Grade Hyaluronic Acid Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Pharma-Grade Hyaluronic Acid Sales by Application

5.1.1 Global Pharma-Grade Hyaluronic Acid Historical Sales by Application (2017-2022)

5.1.2 Global Pharma-Grade Hyaluronic Acid Forecasted Sales by Application (2023-2028)

5.1.3 Global Pharma-Grade Hyaluronic Acid Sales Market Share by Application (2017-2028)

5.2 Global Pharma-Grade Hyaluronic Acid Revenue by Application

5.2.1 Global Pharma-Grade Hyaluronic Acid Historical Revenue by Application (2017-2022)

5.2.2 Global Pharma-Grade Hyaluronic Acid Forecasted Revenue by Application (2023-2028)

5.2.3 Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Application (2017-2028)

5.3 Global Pharma-Grade Hyaluronic Acid Price by Application

5.3.1 Global Pharma-Grade Hyaluronic Acid Price by Application (2017-2022)

5.3.2 Global Pharma-Grade Hyaluronic Acid Price Forecast by Application (2023-2028)

6 North America

6.1 North America Pharma-Grade Hyaluronic Acid Market Size by Type

6.1.1 North America Pharma-Grade Hyaluronic Acid Sales by Type (2017-2028)

6.1.2 North America Pharma-Grade Hyaluronic Acid Revenue by Type (2017-2028)

6.2 North America Pharma-Grade Hyaluronic Acid Market Size by Application

6.2.1 North America Pharma-Grade Hyaluronic Acid Sales by Application (2017-2028)

6.2.2 North America Pharma-Grade Hyaluronic Acid Revenue by Application (2017-2028)

6.3 North America Pharma-Grade Hyaluronic Acid Market Size by Country

6.3.1 North America Pharma-Grade Hyaluronic Acid Sales by Country (2017-2028)

6.3.2 North America Pharma-Grade Hyaluronic Acid Revenue by Country (2017-2028)

6.3.3 United States

6.3.4 Canada

7 Europe

7.1 Europe Pharma-Grade Hyaluronic Acid Market Size by Type

7.1.1 Europe Pharma-Grade Hyaluronic Acid Sales by Type (2017-2028)

7.1.2 Europe Pharma-Grade Hyaluronic Acid Revenue by Type (2017-2028)

7.2 Europe Pharma-Grade Hyaluronic Acid Market Size by Application

7.2.1 Europe Pharma-Grade Hyaluronic Acid Sales by Application (2017-2028)

7.2.2 Europe Pharma-Grade Hyaluronic Acid Revenue by Application (2017-2028)

7.3 Europe Pharma-Grade Hyaluronic Acid Market Size by Country

7.3.1 Europe Pharma-Grade Hyaluronic Acid Sales by Country (2017-2028)

7.3.2 Europe Pharma-Grade Hyaluronic Acid Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Pharma-Grade Hyaluronic Acid Market Size by Type

8.1.1 Asia Pacific Pharma-Grade Hyaluronic Acid Sales by Type (2017-2028)

8.1.2 Asia Pacific Pharma-Grade Hyaluronic Acid Revenue by Type (2017-2028)

8.2 Asia Pacific Pharma-Grade Hyaluronic Acid Market Size by Application

8.2.1 Asia Pacific Pharma-Grade Hyaluronic Acid Sales by Application (2017-2028)

8.2.2 Asia Pacific Pharma-Grade Hyaluronic Acid Revenue by Application (2017-2028)

8.3 Asia Pacific Pharma-Grade Hyaluronic Acid Market Size by Region

8.3.1 Asia Pacific Pharma-Grade Hyaluronic Acid Sales by Region (2017-2028)

8.3.2 Asia Pacific Pharma-Grade Hyaluronic Acid Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America Pharma-Grade Hyaluronic Acid Market Size by Type

9.1.1 Latin America Pharma-Grade Hyaluronic Acid Sales by Type (2017-2028)

9.1.2 Latin America Pharma-Grade Hyaluronic Acid Revenue by Type (2017-2028)

9.2 Latin America Pharma-Grade Hyaluronic Acid Market Size by Application

9.2.1 Latin America Pharma-Grade Hyaluronic Acid Sales by Application (2017-2028)

9.2.2 Latin America Pharma-Grade Hyaluronic Acid Revenue by Application (2017-2028)

9.3 Latin America Pharma-Grade Hyaluronic Acid Market Size by Country

9.3.1 Latin America Pharma-Grade Hyaluronic Acid Sales by Country (2017-2028)

9.3.2 Latin America Pharma-Grade Hyaluronic Acid Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Pharma-Grade Hyaluronic Acid Market Size by Type

10.1.1 Middle East and Africa Pharma-Grade Hyaluronic Acid Sales by Type (2017-2028)

10.1.2 Middle East and Africa Pharma-Grade Hyaluronic Acid Revenue by Type (2017-2028)

10.2 Middle East and Africa Pharma-Grade Hyaluronic Acid Market Size by Application

10.2.1 Middle East and Africa Pharma-Grade Hyaluronic Acid Sales by Application (2017-2028)

10.2.2 Middle East and Africa Pharma-Grade Hyaluronic Acid Revenue by Application (2017-2028)

10.3 Middle East and Africa Pharma-Grade Hyaluronic Acid Market Size by Country

10.3.1 Middle East and Africa Pharma-Grade Hyaluronic Acid Sales by Country (2017-2028)

10.3.2 Middle East and Africa Pharma-Grade Hyaluronic Acid Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Bloomage BioTechnology

11.1.1 Bloomage BioTechnology Corporation Information

11.1.2 Bloomage BioTechnology Overview

11.1.3 Bloomage BioTechnology Pharma-Grade Hyaluronic Acid Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Bloomage BioTechnology Pharma-Grade Hyaluronic Acid Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Bloomage BioTechnology Recent Developments

11.2 AWA Biopharm

11.2.1 AWA Biopharm Corporation Information

11.2.2 AWA Biopharm Overview

11.2.3 AWA Biopharm Pharma-Grade Hyaluronic Acid Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 AWA Biopharm Pharma-Grade Hyaluronic Acid Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 AWA Biopharm Recent Developments

11.3 Kewpie

11.3.1 Kewpie Corporation Information

11.3.2 Kewpie Overview

11.3.3 Kewpie Pharma-Grade Hyaluronic Acid Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Kewpie Pharma-Grade Hyaluronic Acid Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Kewpie Recent Developments

11.4 Contipro

11.4.1 Contipro Corporation Information

11.4.2 Contipro Overview

11.4.3 Contipro Pharma-Grade Hyaluronic Acid Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Contipro Pharma-Grade Hyaluronic Acid Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Contipro Recent Developments

11.5 Seikagaku

11.5.1 Seikagaku Corporation Information

11.5.2 Seikagaku Overview

11.5.3 Seikagaku Pharma-Grade Hyaluronic Acid Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Seikagaku Pharma-Grade Hyaluronic Acid Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Seikagaku Recent Developments

11.6 HTL Biotechnology

11.6.1 HTL Biotechnology Corporation Information

11.6.2 HTL Biotechnology Overview

11.6.3 HTL Biotechnology Pharma-Grade Hyaluronic Acid Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 HTL Biotechnology Pharma-Grade Hyaluronic Acid Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 HTL Biotechnology Recent Developments

11.7 Fidia Farmaceutici

11.7.1 Fidia Farmaceutici Corporation Information

11.7.2 Fidia Farmaceutici Overview

11.7.3 Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Fidia Farmaceutici Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Pharma-Grade Hyaluronic Acid Industry Chain Analysis

12.2 Pharma-Grade Hyaluronic Acid Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Pharma-Grade Hyaluronic Acid Production Mode & Process

12.4 Pharma-Grade Hyaluronic Acid Sales and Marketing

12.4.1 Pharma-Grade Hyaluronic Acid Sales Channels

12.4.2 Pharma-Grade Hyaluronic Acid Distributors

12.5 Pharma-Grade Hyaluronic Acid Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Pharma-Grade Hyaluronic Acid Industry Trends

13.2 Pharma-Grade Hyaluronic Acid Market Drivers

13.3 Pharma-Grade Hyaluronic Acid Market Challenges

13.4 Pharma-Grade Hyaluronic Acid Market Restraints

14 Key Findings in The Global Pharma-Grade Hyaluronic Acid Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Delivery Format : EXCEL/Data Pack

Choose License Type

Checkout Inquiry Sample